Invetx: Boehringer Ingelheim, Invetx collaborate to advance monoclonal antibody biotherapeutics in animal health
Boehringer Ingelheim, a global leader in animal health, and Invetx, a Boston─based pioneer in protein─based therapeutics for animal health, announced that they have entered into a collaboration agreement to
Read full article »
Invetx is a Massachusetts-based biopharmaceutical company that researches and develops veterinary monoclonal antibodies for animal health conditions.
Read more